Forest/Cypress Fibromyalgia Treatment Milnacipran Aims To Take On Pfizer’s Lyrica With More Robust Data

Cypress Chief Business Officer tells the DAILY that use of a more stringent composite endpoint could provide advantage for milnacipran over Lyrica and other potential treatments.